BRAIN Biotech AG

BATS-CHIXE:BNND Stock Report

Market Cap: €130.2m

BRAIN Biotech Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Aryan Moelker

Chief executive officer

€957.0k

Total compensation

CEO salary percentage43.9%
CEO tenure2.8yrs
CEO ownershipn/a
Management average tenure2.5yrs
Board average tenure3.8yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Aryan Moelker's remuneration changed compared to BRAIN Biotech's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2022n/an/a

-€8m

Mar 31 2022n/an/a

-€8m

Dec 31 2021n/an/a

-€4m

Sep 30 2021€957k€420k

-€5m

Jun 30 2021n/an/a

-€6m

Mar 31 2021n/an/a

-€6m

Dec 31 2020n/an/a

-€11m

Sep 30 2020€885k€280k

-€10m

Compensation vs Market: Aryan's total compensation ($USD1.01M) is above average for companies of similar size in the UK market ($USD348.41K).

Compensation vs Earnings: Aryan's compensation has increased whilst the company is unprofitable.

CEO

Aryan Moelker

2.8yrs

Tenure

€957,000

Compensation

Mr. Adriaan Moelker, also known as Aryan, serves as Director of SolasCure Limited. He has been Chairman of the Management Board and Chief Executive Officer of BRAIN Biotech AG (formerly known as B.R.A.I.N....

Leadership Team

NamePositionTenureCompensationOwnership
Adriaan Moelker
Chairman of the Management Board & CEO2.8yrs€957.00kno data
Ulrich Putsch
Co-Founderno datano datano data
Michael Schneiders
CFO & Member of Management Boardless than a yearno datano data
Ute Dechert
Vice President of Human Resources & Processes2.2yrsno datano data
Jurgen Eck
Consultant3yrs€392.00kno data
Martin Langer
Executive VP & Head of Business Developmentno datano datano data
Michael Krohn
Executive VP and Head of Research & Developmentno datano datano data
Thomas Deichmann
Head of Public Relationsno datano datano data
Michael Waidelich
Head of Skin Care Business Unit3.9yrsno datano data
Robbert Hoekstra
Head of Group Financeless than a yearno datano data
Paul Scholz
Technical Lead of Genome Editing Developmentno datano datano data

2.5yrs

Average Tenure

57yo

Average Age

Experienced Management: BNND's management team is considered experienced (2.5 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Georg Kellinghusen
Independent Chairman of the Supervisory Board5.8yrs€66.00kno data
Wiltrud Treffenfeldt
Member of Supervisory Board2.2yrs€28.00kno data
Stephen Catling
Member of Supervisory Board2.2yrs€31.00kno data
Michael Majerus
Independent Member of Supervisory Board3.8yrs€51.00kno data
Anna Eichhorn
Vice Chairwoman of the Supervisory Board5.8yrs€53.00kno data

3.8yrs

Average Tenure

61yo

Average Age

Experienced Board: BNND's board of directors are considered experienced (3.8 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2022/12/19 16:40
End of Day Share Price 2022/09/21 00:00
Earnings2022/06/30
Annual Earnings2021/09/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

BRAIN Biotech AG is covered by 12 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Volker BosseBaader Helvea Equity Research
Thomas MeyerBaader Helvea Equity Research
Laura Lopez PinedaBaader Helvea Equity Research